Literature DB >> 9663628

Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group.

T Diaz1, S Y Chu, B Weinstein, E Mokotoff, T S Jones.   

Abstract

Because HIV-infected injection drug users (IDUs) can transmit HIV infection, we investigated factors associated with sharing of syringes in the past year among IDUs infected with HIV. We analyzed data from an interview survey of 11,757 persons > or = 18 years of age with HIV or AIDS between June 1990 and August 1995 who were reported to 12 state or city health departments in the United States. Of the 1527 persons who had ever shared syringes and reported injecting in the 5 years before the interview, 786 (51%) had injected in the year before interview, and of these, 391 (50%) had shared during that year. IDUs who were aware of their HIV infection for >1 year were less likely to share (43%) than those who were aware of their infection for 1 year or less (65%, adjusted odds ratio=2.15, 95% confidence interval, 1.52-3.03). The only statistically significant time trend was that the proportion of IDUs from Connecticut who shared decreased from 71% in 1992 to 29% in 1995. This trend appears to be related to the 1992 changes in Connecticut laws that allowed purchase and possession of syringes without a prescription. Because many HIV-infected IDUs continue to inject and share, prevention efforts should be aimed at HIV-infected IDUs to prevent transmission of HIV. Early HIV diagnosis and access to sterile syringes may be important methods for reducing syringe sharing by HIV-infected IDUs.

Entities:  

Mesh:

Year:  1998        PMID: 9663628     DOI: 10.1097/00042560-199802001-00014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  5 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Addressing urban health in Detroit, New York City, and Seattle through community-based participatory research partnerships.

Authors:  Marilyn M Metzler; Donna L Higgins; Carolyn G Beeker; Nicholas Freudenberg; Paula M Lantz; Kirsten D Senturia; Alison A Eisinger; Edna A Viruell-Fuentes; Bookda Gheisar; Ann-Gel Palermo; Donald Softley
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

3.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

4.  Injecting drug users' experiences of policing practices in two Mexican-U.S. border cities: public health perspectives.

Authors:  Cari L Miller; Michelle Firestone; Rebeca Ramos; Scott Burris; Maria Elena Ramos; Patricia Case; Kimberly C Brouwer; Miguel Angel Fraga; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2007-11-09

5.  The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.

Authors:  Daniel J Escudero; Mark N Lurie; Kenneth H Mayer; Maximilian King; Sandro Galea; Samuel R Friedman; Brandon D L Marshall
Journal:  BMC Public Health       Date:  2017-07-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.